G6PD and Parkinson disease: In the present study, we provided the first evidence that G6PD-mediated metabolic dysfunction in the PPP in brain microglia and neuroinflammation exacerbated each other inducing chronic neurodegeneration and locomotor impairment, thus identifying a mechanistic basis for chronic PD progression.